nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.0024	0.0201	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.00227	0.019	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00223	0.0187	CbGpPWpGaD
Acamprosate—GABRB3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00215	0.018	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00212	0.0177	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00202	0.0169	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00196	0.0164	CbGpPWpGaD
Acamprosate—GABRB3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00192	0.0161	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00189	0.0158	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00185	0.0155	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00183	0.0153	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00182	0.0152	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.0018	0.0151	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0018	0.0151	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00168	0.014	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00165	0.0138	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.0016	0.0134	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00156	0.013	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00149	0.0125	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00147	0.0123	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00138	0.0116	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00138	0.0115	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00137	0.0114	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.0013	0.0109	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00128	0.0107	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00127	0.0106	CbGpPWpGaD
Acamprosate—GRM5—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00126	0.0106	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.0012	0.01	CbGpPWpGaD
Acamprosate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00134	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00134	CcSEcCtD
Acamprosate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00134	CcSEcCtD
Acamprosate—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Acamprosate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00117	0.00979	CbGpPWpGaD
Acamprosate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00133	CcSEcCtD
Acamprosate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00132	CcSEcCtD
Acamprosate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00132	CcSEcCtD
Acamprosate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00132	CcSEcCtD
Acamprosate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00131	CcSEcCtD
Acamprosate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00131	CcSEcCtD
Acamprosate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00131	CcSEcCtD
Acamprosate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.0013	CcSEcCtD
Acamprosate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.0013	CcSEcCtD
Acamprosate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.0013	CcSEcCtD
Acamprosate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.0013	CcSEcCtD
Acamprosate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00129	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00114	0.00951	CbGpPWpGaD
Acamprosate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00129	CcSEcCtD
Acamprosate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00129	CcSEcCtD
Acamprosate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00129	CcSEcCtD
Acamprosate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00129	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00113	0.00945	CbGpPWpGaD
Acamprosate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00128	CcSEcCtD
Acamprosate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00128	CcSEcCtD
Acamprosate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00128	CcSEcCtD
Acamprosate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00128	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00113	0.00942	CbGpPWpGaD
Acamprosate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00128	CcSEcCtD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00112	0.00939	CbGpPWpGaD
Acamprosate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00127	CcSEcCtD
Acamprosate—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00127	CcSEcCtD
Acamprosate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00126	CcSEcCtD
Acamprosate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00126	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00111	0.00925	CbGpPWpGaD
Acamprosate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00125	CcSEcCtD
Acamprosate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00124	CcSEcCtD
Acamprosate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00124	CcSEcCtD
Acamprosate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00123	CcSEcCtD
Acamprosate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00123	CcSEcCtD
Acamprosate—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00123	CcSEcCtD
Acamprosate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00123	CcSEcCtD
Acamprosate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00122	CcSEcCtD
Acamprosate—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00122	CcSEcCtD
Acamprosate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00121	CcSEcCtD
Acamprosate—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00121	CcSEcCtD
Acamprosate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00121	CcSEcCtD
Acamprosate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.0012	CcSEcCtD
Acamprosate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.0012	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00106	0.0012	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.0012	CcSEcCtD
Acamprosate—GRIN2A—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00105	0.00882	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00105	0.00881	CbGpPWpGaD
Acamprosate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00119	CcSEcCtD
Acamprosate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00119	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00105	0.00876	CbGpPWpGaD
Acamprosate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00119	CcSEcCtD
Acamprosate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00118	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00118	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00103	0.00866	CbGpPWpGaD
Acamprosate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Acamprosate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Acamprosate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Acamprosate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Acamprosate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00117	CcSEcCtD
Acamprosate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Acamprosate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Acamprosate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Acamprosate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Acamprosate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00116	CcSEcCtD
Acamprosate—Injury—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00115	CcSEcCtD
Acamprosate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00115	CcSEcCtD
Acamprosate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00115	CcSEcCtD
Acamprosate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00114	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00114	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.001	0.00114	CcSEcCtD
Acamprosate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.001	0.00114	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000998	0.00113	CcSEcCtD
Acamprosate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000992	0.00113	CcSEcCtD
Acamprosate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000992	0.00113	CcSEcCtD
Acamprosate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000992	0.00113	CcSEcCtD
Acamprosate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000992	0.00113	CcSEcCtD
Acamprosate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000991	0.00113	CcSEcCtD
Acamprosate—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000989	0.00112	CcSEcCtD
Acamprosate—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000989	0.00112	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000989	0.00827	CbGpPWpGaD
Acamprosate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000984	0.00112	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000983	0.00823	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000981	0.00111	CcSEcCtD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000979	0.00819	CbGpPWpGaD
Acamprosate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000977	0.00111	CcSEcCtD
Acamprosate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000974	0.00111	CcSEcCtD
Acamprosate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000972	0.0011	CcSEcCtD
Acamprosate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000971	0.0011	CcSEcCtD
Acamprosate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000969	0.0011	CcSEcCtD
Acamprosate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000966	0.0011	CcSEcCtD
Acamprosate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000964	0.0011	CcSEcCtD
Acamprosate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000961	0.00109	CcSEcCtD
Acamprosate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00096	0.00109	CcSEcCtD
Acamprosate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000956	0.00109	CcSEcCtD
Acamprosate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000956	0.00109	CcSEcCtD
Acamprosate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000955	0.00108	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000954	0.00798	CbGpPWpGaD
Acamprosate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000952	0.00108	CcSEcCtD
Acamprosate—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000952	0.00108	CcSEcCtD
Acamprosate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000951	0.00108	CcSEcCtD
Acamprosate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000949	0.00108	CcSEcCtD
Acamprosate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000949	0.00108	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000946	0.00107	CcSEcCtD
Acamprosate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.00106	CcSEcCtD
Acamprosate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.00106	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000931	0.00779	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000929	0.00106	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000929	0.00106	CcSEcCtD
Acamprosate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000922	0.00105	CcSEcCtD
Acamprosate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000922	0.00105	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00092	0.0077	CbGpPWpGaD
Acamprosate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.00104	CcSEcCtD
Acamprosate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.00104	CcSEcCtD
Acamprosate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000917	0.00104	CcSEcCtD
Acamprosate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000917	0.00104	CcSEcCtD
Acamprosate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000914	0.00104	CcSEcCtD
Acamprosate—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000907	0.00103	CcSEcCtD
Acamprosate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000907	0.00103	CcSEcCtD
Acamprosate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000906	0.00103	CcSEcCtD
Acamprosate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000906	0.00103	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000904	0.00757	CbGpPWpGaD
Acamprosate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000903	0.00103	CcSEcCtD
Acamprosate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000903	0.00103	CcSEcCtD
Acamprosate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000901	0.00102	CcSEcCtD
Acamprosate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000898	0.00102	CcSEcCtD
Acamprosate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000898	0.00102	CcSEcCtD
Acamprosate—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000897	0.00102	CcSEcCtD
Acamprosate—GRIN2B—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000897	0.0075	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000896	0.00102	CcSEcCtD
Acamprosate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000889	0.00101	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000887	0.00742	CbGpPWpGaD
Acamprosate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000884	0.001	CcSEcCtD
Acamprosate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00087	0.000989	CcSEcCtD
Acamprosate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.000984	CcSEcCtD
Acamprosate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.000984	CcSEcCtD
Acamprosate—GRIN2A—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00086	0.00719	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000859	0.00719	CbGpPWpGaD
Acamprosate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000855	0.000971	CcSEcCtD
Acamprosate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000855	0.000971	CcSEcCtD
Acamprosate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000854	0.00097	CcSEcCtD
Acamprosate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000852	0.000968	CcSEcCtD
Acamprosate—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000852	0.000967	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000843	0.00706	CbGpPWpGaD
Acamprosate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000837	0.000951	CcSEcCtD
Acamprosate—GRIN2C—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000835	0.00699	CbGpPWpGaD
Acamprosate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000833	0.000946	CcSEcCtD
Acamprosate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000833	0.000946	CcSEcCtD
Acamprosate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000821	0.000932	CcSEcCtD
Acamprosate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000821	0.000932	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000819	0.000931	CcSEcCtD
Acamprosate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000815	0.000926	CcSEcCtD
Acamprosate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000808	0.000918	CcSEcCtD
Acamprosate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000807	0.000917	CcSEcCtD
Acamprosate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000804	0.000913	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000797	0.00667	CbGpPWpGaD
Acamprosate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000794	0.000902	CcSEcCtD
Acamprosate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000794	0.000902	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000792	0.00663	CbGpPWpGaD
Acamprosate—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000787	0.000894	CcSEcCtD
Acamprosate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.000893	CcSEcCtD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000778	0.00651	CbGpPWpGaD
Acamprosate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000778	0.000883	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000776	0.00649	CbGpPWpGaD
Acamprosate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000775	0.00088	CcSEcCtD
Acamprosate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000767	0.000871	CcSEcCtD
Acamprosate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000767	0.000871	CcSEcCtD
Acamprosate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000752	0.000854	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00075	0.00627	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00075	0.00627	CbGpPWpGaD
Acamprosate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00075	0.000851	CcSEcCtD
Acamprosate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00074	0.00084	CcSEcCtD
Acamprosate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000738	0.000838	CcSEcCtD
Acamprosate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000738	0.000838	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000737	0.00617	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000736	0.00616	CbGpPWpGaD
Acamprosate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000732	0.000831	CcSEcCtD
Acamprosate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000732	0.000831	CcSEcCtD
Acamprosate—GRIN2B—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000731	0.00612	CbGpPWpGaD
Acamprosate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000731	0.00083	CcSEcCtD
Acamprosate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000731	0.00083	CcSEcCtD
Acamprosate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000731	0.00083	CcSEcCtD
Acamprosate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.000826	CcSEcCtD
Acamprosate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000727	0.000826	CcSEcCtD
Acamprosate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000726	0.000825	CcSEcCtD
Acamprosate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.000823	CcSEcCtD
Acamprosate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000724	0.000823	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000724	0.00605	CbGpPWpGaD
Acamprosate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000723	0.000821	CcSEcCtD
Acamprosate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000717	0.000814	CcSEcCtD
Acamprosate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000716	0.000813	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000714	0.000811	CcSEcCtD
Acamprosate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000714	0.000811	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000713	0.00597	CbGpPWpGaD
Acamprosate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000712	0.000809	CcSEcCtD
Acamprosate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000706	0.000802	CcSEcCtD
Acamprosate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000704	0.000799	CcSEcCtD
Acamprosate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000702	0.000797	CcSEcCtD
Acamprosate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.000791	CcSEcCtD
Acamprosate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000694	0.000789	CcSEcCtD
Acamprosate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000692	0.000786	CcSEcCtD
Acamprosate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.000785	CcSEcCtD
Acamprosate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00069	0.000784	CcSEcCtD
Acamprosate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00069	0.000784	CcSEcCtD
Acamprosate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000689	0.000783	CcSEcCtD
Acamprosate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000689	0.000783	CcSEcCtD
Acamprosate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.00078	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00068	0.00569	CbGpPWpGaD
Acamprosate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000677	0.000769	CcSEcCtD
Acamprosate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000675	0.000767	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000668	0.00559	CbGpPWpGaD
Acamprosate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000667	0.000758	CcSEcCtD
Acamprosate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000665	0.000755	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000656	0.00549	CbGpPWpGaD
Acamprosate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.000739	CcSEcCtD
Acamprosate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000648	0.000736	CcSEcCtD
Acamprosate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000646	0.000734	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000646	0.0054	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000643	0.00538	CbGpPWpGaD
Acamprosate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000643	0.00073	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000642	0.00537	CbGpPWpGaD
Acamprosate—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00064	0.000726	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000637	0.00533	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000637	0.00533	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000634	0.0053	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000633	0.00529	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000628	0.000714	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.00062	0.00519	CbGpPWpGaD
Acamprosate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000618	0.000702	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000615	0.00515	CbGpPWpGaD
Acamprosate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000613	0.000697	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000607	0.00069	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000607	0.00508	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000606	0.00507	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000596	0.00499	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.00059	0.00493	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000583	0.00488	CbGpPWpGaD
Acamprosate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000581	0.000659	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000574	0.0048	CbGpPWpGaD
Acamprosate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000568	0.000646	CcSEcCtD
Acamprosate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000568	0.000645	CcSEcCtD
Acamprosate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000564	0.000641	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000564	0.00472	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000563	0.00471	CbGpPWpGaD
Acamprosate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000563	0.00064	CcSEcCtD
Acamprosate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00056	0.000635	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000558	0.00466	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000557	0.00466	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000556	0.00465	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000554	0.00464	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000544	0.00455	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000542	0.00453	CbGpPWpGaD
Acamprosate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000537	0.00061	CcSEcCtD
Acamprosate—GRIN2C—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000534	0.00447	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000521	0.00436	CbGpPWpGaD
Acamprosate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000519	0.00059	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000518	0.000588	CcSEcCtD
Acamprosate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000517	0.000587	CcSEcCtD
Acamprosate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000514	0.000584	CcSEcCtD
Acamprosate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000511	0.000581	CcSEcCtD
Acamprosate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000505	0.000573	CcSEcCtD
Acamprosate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000503	0.000571	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000502	0.0042	CbGpPWpGaD
Acamprosate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000502	0.00057	CcSEcCtD
Acamprosate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.000567	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000497	0.00415	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000495	0.00414	CbGpPWpGaD
Acamprosate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000559	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000486	0.00406	CbGpPWpGaD
Acamprosate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000485	0.000551	CcSEcCtD
Acamprosate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000549	CcSEcCtD
Acamprosate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000476	0.000541	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000476	0.000541	CcSEcCtD
Acamprosate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000475	0.000539	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000473	0.000537	CcSEcCtD
Acamprosate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000471	0.000535	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000469	0.00392	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000463	0.000526	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000463	0.00387	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000457	0.000519	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	0.000456	0.00382	CbGpPWpGaD
Acamprosate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000515	CcSEcCtD
Acamprosate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000449	0.00051	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000446	0.00373	CbGpPWpGaD
Acamprosate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000446	0.000506	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	0.000445	0.00372	CbGpPWpGaD
Acamprosate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000444	0.000504	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000441	0.000501	CcSEcCtD
Acamprosate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000435	0.000494	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000428	0.00358	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000425	0.00355	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.00042	0.00352	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000416	0.000473	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000416	0.000472	CcSEcCtD
Acamprosate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000469	CcSEcCtD
Acamprosate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00041	0.000466	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	0.00041	0.00343	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000408	0.00341	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000403	0.00338	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000403	0.00337	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000403	0.00337	CbGpPWpGaD
Acamprosate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000402	0.000457	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	0.000399	0.00334	CbGpPWpGaD
Acamprosate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000397	0.000451	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000397	0.00332	CbGpPWpGaD
Acamprosate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.00045	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.00045	CcSEcCtD
Acamprosate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.000447	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000393	0.00329	CbGpPWpGaD
Acamprosate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00039	0.000444	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.00038	0.00318	CbGpPWpGaD
Acamprosate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000427	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000424	CcSEcCtD
Acamprosate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000373	0.000424	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000366	0.00306	CbGpPWpGaD
Acamprosate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000412	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00041	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00041	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00036	0.00301	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000356	0.00298	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000348	0.00291	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000347	0.0029	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000345	0.00288	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000344	0.00288	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000343	0.00287	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000336	0.000382	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000336	0.00281	CbGpPWpGaD
Acamprosate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000372	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000327	0.00274	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000324	0.00271	CbGpPWpGaD
Acamprosate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000367	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000323	0.0027	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000316	0.00264	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000315	0.00264	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000313	0.00262	CbGpPWpGaD
Acamprosate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000312	0.000355	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000308	0.00258	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000307	0.00257	CbGpPWpGaD
Acamprosate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000302	0.000343	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000293	0.00245	CbGpPWpGaD
Acamprosate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00033	CcSEcCtD
Acamprosate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000327	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000327	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000286	0.00239	CbGpPWpGaD
Acamprosate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000325	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000273	0.00229	CbGpPWpGaD
Acamprosate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000308	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	0.000258	0.00216	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000252	0.00211	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000238	0.00199	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	0.000236	0.00198	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000234	0.00196	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000234	0.00196	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000216	0.00181	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000201	0.00168	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000196	0.00164	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000195	0.00163	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000193	0.00162	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00019	0.00159	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000189	0.00158	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000183	0.00153	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000177	0.00148	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000176	0.00147	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.00017	0.00142	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000169	0.00141	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000165	0.00138	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000157	0.00131	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000155	0.00129	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000152	0.00127	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000148	0.00124	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000147	0.00123	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000144	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000137	0.00115	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000134	0.00112	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000133	0.00111	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000129	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000126	0.00106	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000123	0.00103	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000121	0.00101	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000118	0.000986	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000118	0.000985	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000109	0.000909	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000107	0.000895	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000106	0.000886	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000105	0.000881	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000104	0.000874	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000103	0.000859	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	9.97e-05	0.000834	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.93e-05	0.000831	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	9.78e-05	0.000818	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	9.72e-05	0.000813	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—chronic obstructive pulmonary disease	9.53e-05	0.000797	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.44e-05	0.00079	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—chronic obstructive pulmonary disease	9.31e-05	0.000779	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—chronic obstructive pulmonary disease	9.08e-05	0.000759	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.83e-05	0.000739	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.67e-05	0.000725	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.48e-05	0.000709	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.78e-05	0.000651	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.63e-05	0.000638	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.58e-05	0.000634	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—chronic obstructive pulmonary disease	7.51e-05	0.000628	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—chronic obstructive pulmonary disease	7.32e-05	0.000613	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.41e-05	0.000536	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.87e-05	0.000491	CbGpPWpGaD
